Geetha P. Bansal - Concepedia

Author

Geetha P. Bansal

Also Known As

G Bansal, G P Bansal, G. P. Bansal, GEETHA P. BANSAL, Garv Bansal, Geetha Bansal, Geetha P Bansal, Geetha P. Bansal, Gunjan Bansal, Veronica Tutse-Tonwe

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Tulane University National Institutes of Health Ichor Medical Systems (United States)University of KwaZulu-Natal University of Zimbabwe

About

Geetha P. Bansal is an author at Tulane University specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	20	2.4K
2	Engineering	5	5	171
3	Biomolecular Engineering	3	3	133
4	Allergy	2	2	118
5	Biomedical Engineering	1	1	22

Geetha P. Bansal

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
New use of BCG for recombinant vaccines C. Kendall Stover, Vidal F. de la Cruz, Thomas R. Fuerst, Nature VaccinationVaccinologyVaccine DevelopmentImmunologyNew Use	1991	1.5K
Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus Syd Johnson, Cynthia N. Oliver, Gregory A. Prince, The Journal of Infectious Diseases	1997	636
Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. C. Kendall Stover, Geetha P. Bansal, Mark S. Hanson, The Journal of Experimental Medicine Vaccine ResearchMicrobial PathogensHumoral ResponseImmunologyBcg Growth	1993	268
Candidate Recombinant Vaccine for Human B19 Parvovirus Geetha P. Bansal, Jeanine Hatfield, Frances Dunn, The Journal of Infectious Diseases	1993	134
Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. Stephen J. Rosenfeld, Kohji Yoshimoto, Sachiko Kajigaya, Journal of Clinical Investigation Unique RegionVirus StructureVirion SurfaceMinor Capsid ProteinMolecular Virology	1992	108
Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles Rajesh Kumar, Paresh Chandra Ray, Dibyadyuti Datta, Vaccine NanoparticlesNanomedicineEngineeringMetal NanoparticlesNanomaterials	2015	94
Bacterial cell wall-induced immunosuppression. Role of transforming growth factor beta. Sharon M. Wahl, D A Hunt, Geetha P. Bansal, The Journal of Experimental Medicine Microbial PathogensT-regulatory CellBacteriologyImmunologyImmune Regulation	1988	89
Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine Robert Edelman, Kathleen Palmer, Karin Russ, Vaccine VaccinationVeterinary VaccineVaccine DevelopmentRecombinant Bacille Calmette-guérinImmunology	1999	68
Dominant recognition of a Borrelia burgdorferi outer surface protein A peptide by T helper cells in patients with treatment-resistant Lyme arthritis Thomas Kamradt, B Lengl-Janßen, Ann Strauss, Infection and Immunity ImmunologyAntigen ProcessingOspa PeptidesImmunotherapyTick-borne Disease	1996	67
Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates Marjorie Robert-Guroff, Kristine Aldrich, Rebecca R. Muldoon, Journal of Virology Primary ImmunodeficiencyHuman RetrovirusLoop ConformationImmunologyAntiviral Response	1992	65

Page 1